Olema Pharmaceuticals (OLMA) Capital Expenditures (2020 - 2024)

Olema Pharmaceuticals (OLMA) has 4 years of Capital Expenditures data on file, last reported at $6000.0 in Q2 2024.

• Capital Expenditures for Q2 2024 came in at $6000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $6000.0 (down 98.19% YoY), and the FY2024 annual result was $159000.0, changed N/A from the prior year.
• Capital Expenditures fell to $6000.0 in Q2 2024 per OLMA's latest filing, from $153000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $741000.0 in Q2 2021 and troughed at -$10000.0 in Q3 2020.
• A 4-year average of $153785.7 and a median of $45000.0 in 2020 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2021 and 2022: Capital Expenditures surged 12250.0% in 2021, then tumbled 97.17% in 2022.
• A 4-year view of Capital Expenditures shows it stood at $51000.0 in 2020, then surged by 1270.59% to $699000.0 in 2021, then tumbled by 75.25% to $173000.0 in 2022, then plunged by 96.53% to $6000.0 in 2024.
• Business Quant data shows OLMA's Capital Expenditures at $6000.0 in Q2 2024, $153000.0 in Q1 2024, and $173000.0 in Q4 2022.